404 related articles for article (PubMed ID: 10446376)
21. Respiratory survival mechanisms in acetylcholinesterase knockout mouse.
Chatonnet F; Boudinot E; Chatonnet A; Taysse L; Daulon S; Champagnat J; Foutz AS
Eur J Neurosci; 2003 Sep; 18(6):1419-27. PubMed ID: 14511322
[TBL] [Abstract][Full Text] [Related]
22. Structural aspects of 4-aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Bosak A; Opsenica DM; Šinko G; Zlatar M; Kovarik Z
Chem Biol Interact; 2019 Aug; 308():101-109. PubMed ID: 31100281
[TBL] [Abstract][Full Text] [Related]
23. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.
Darvesh S; Darvesh KV; McDonald RS; Mataija D; Walsh R; Mothana S; Lockridge O; Martin E
J Med Chem; 2008 Jul; 51(14):4200-12. PubMed ID: 18570368
[TBL] [Abstract][Full Text] [Related]
24. Evolution of acetylcholinesterase and butyrylcholinesterase in the vertebrates: an atypical butyrylcholinesterase from the Medaka Oryzias latipes.
Pezzementi L; Nachon F; Chatonnet A
PLoS One; 2011 Feb; 6(2):e17396. PubMed ID: 21364766
[TBL] [Abstract][Full Text] [Related]
25. Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions.
Minic J; Chatonnet A; Krejci E; Molgó J
Br J Pharmacol; 2003 Jan; 138(1):177-87. PubMed ID: 12522088
[TBL] [Abstract][Full Text] [Related]
26. Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase?
Kaplan D; Ordentlich A; Barak D; Ariel N; Kronman C; Velan B; Shafferman A
Biochemistry; 2001 Jun; 40(25):7433-45. PubMed ID: 11412096
[TBL] [Abstract][Full Text] [Related]
27. Mice heterozygous for AChE are more sensitive to AChE inhibitors but do not respond to BuChE inhibition.
Mohr F; Zimmermann M; Klein J
Neuropharmacology; 2013 Apr; 67():37-45. PubMed ID: 23147415
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
[TBL] [Abstract][Full Text] [Related]
29. Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase.
Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
Bioorg Chem; 2018 Oct; 80():668-673. PubMed ID: 30059892
[TBL] [Abstract][Full Text] [Related]
30. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors.
Horáková E; Drabina P; Brož B; Štěpánková Š; Vorčáková K; Královec K; Havelek R; Sedlák M
J Enzyme Inhib Med Chem; 2016; 31(sup3):173-179. PubMed ID: 27476673
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
[TBL] [Abstract][Full Text] [Related]
33. Active site mutant acetylcholinesterase interactions with 2-PAM, HI-6, and DDVP.
Kovarik Z; Ciban N; Radić Z; Simeon-Rudolf V; Taylor P
Biochem Biophys Res Commun; 2006 Apr; 342(3):973-8. PubMed ID: 16598855
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study.
Rosenberry TL; Brazzolotto X; Macdonald IR; Wandhammer M; Trovaslet-Leroy M; Darvesh S; Nachon F
Molecules; 2017 Nov; 22(12):. PubMed ID: 29186056
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological evaluation of bambuterol analogues as novel inhibitors of butyrylcholinesterase.
Wu J; Tian Y; Wang S; Pistolozzi M; Jin Y; Zhou T; Roy G; Xu L; Tan W
Eur J Med Chem; 2017 Jan; 126():61-71. PubMed ID: 27744187
[TBL] [Abstract][Full Text] [Related]
36. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse.
Li B; Stribley JA; Ticu A; Xie W; Schopfer LM; Hammond P; Brimijoin S; Hinrichs SH; Lockridge O
J Neurochem; 2000 Sep; 75(3):1320-31. PubMed ID: 10936216
[TBL] [Abstract][Full Text] [Related]
37. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors.
Radić Z; Pickering NA; Vellom DC; Camp S; Taylor P
Biochemistry; 1993 Nov; 32(45):12074-84. PubMed ID: 8218285
[TBL] [Abstract][Full Text] [Related]
38. Substrate activation in acetylcholinesterase induced by low pH or mutation in the pi-cation subsite.
Masson P; Schopfer LM; Bartels CF; Froment MT; Ribes F; Nachon F; Lockridge O
Biochim Biophys Acta; 2002 Feb; 1594(2):313-24. PubMed ID: 11904227
[TBL] [Abstract][Full Text] [Related]
39. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
Loewenstein Y; Gnatt A; Neville LF; Soreq H
J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
[TBL] [Abstract][Full Text] [Related]
40. A new method to characterize the kinetics of cholinesterases inhibited by carbamates.
Xiao Q; Zhou H; Wei H; Du H; Tan W; Zhan Y; Pistolozzi M
J Pharm Biomed Anal; 2017 Sep; 144():175-182. PubMed ID: 28483282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
